Search Science Hub

Science Hub is Novo Nordisk’s one-stop portal for all our scientific publications and clinical trials, congress materials and medical updates. Sign up to gain full access.

Welcome to Novo Nordisk Science Hub

Are you a healthcare professional?

AAN 2026 18 - 22 April 2026

Semaglutide Impacts Proteomic Signatures Related to Dementia Risk in the SELECT Cardiovascular Outcomes Trial

Authors :

Dylan Belmont-Rausch¹, MartíJiménezMausbach¹, JanChristianRefsgaard¹,GabrielMartino¹,TeresaLeonColombo¹,BettyTijms²,ClarePaterson³

Affiliations

View Details Hide Details

Download .PDF

Keywords

Neurodegenerative diseases

Congress poster

GLP-1 RA

Semaglutide

PHASE 3 (RCT)